Potassium Chloride Extended-Release Tablets from Canada
Sustained-release tablets providing controlled potassium ion release to prevent hypokalemia. Primarily affects electrolytic balance in patients on diuretics. Classified in HTS 3004.90.92.67 as measured-dose therapeutic preparation.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include dissolution profile data proving extended-release mechanism
• Specify mg dosage per tablet; varying strengths may need separate entries
• Bioequivalence studies help distinguish from simple chemical salts